Language
News

Ustar Receives MHRA Approval for EasyNAT Monkeypox Virus Assay

  • Categories:Latest News
  • Author:
  • Origin:
  • Time of issue:2022-09-27
  • Views:0

(Summary description)Ustar has recently received an approval for our EasyNAT Monkeypox Virus Assay from MHRA.

Ustar Receives MHRA Approval for EasyNAT Monkeypox Virus Assay

(Summary description)Ustar has recently received an approval for our EasyNAT Monkeypox Virus Assay from MHRA.

  • Categories:Latest News
  • Author:
  • Origin:
  • Time of issue:2022-09-27
  • Views:0
Information

Ustar has recently received an approval for our EasyNAT Monkeypox Virus Assay from the Medicines & Healthcare products Regulatory Agency (MHRA).

According to the latest report of WHO, the number of confirmed cases has exceeded 60,000 cases, affecting more than 100 countries and regions, the European region and regions of the Americas  have become the two largest regions affected by the monkeypox epidemic.

 Source: WHO

Since the CE certification in May this year, our EasyNAT Monkeypox Virus Assay has been sold to the United States, the United Kingdom, Italy, the Netherlands, Spain, Malaysia and other countries and regions, helping more than 30 countries and regions to improve the detection capacity of monkeypox virus, providing a strong guarantee for the prevention and control of monkeypox epidemic with scientific and technological innovation.

EasyNAT® Molecular Testing Platform for Monkeypox Virus

 

The EasyNAT Molecular Testing Platform for Monkeypox Virus is a highly integrated point-of-care testing system integrating sampling and addition of samples in one step. It is applicable for oropharyngeal swab or skin lesion exudate samples and report result within 30 minutes automatically.

---"Swab in, result out": not require additional VTM&BSC, simple workflow friendly to laymens.
---Biosafe: integrated processes of sample lysis, purification, amplification and detection in a sealed cartridge without the need to open the cartridge twice, maximizing the risk of cross-contamination.
---Applicable for primary-level medical units, tent hospitals, mobile detection, and airport customs.
---Affordable: ambient transportation with glassified reagent reducing shipping costs.

Scan the QR code to read on your phone

News

Ustar at Medlab Middle East 2023
Ustar at Medlab Middle East 2023
Time of issue : 2023-02-13 16:20:31
See more information
MDSAP Certificate Obtained!
MDSAP Certificate Obtained!
Time of issue : 2022-11-07 12:11:43
See more information
 Ustar Wins Two GCD Design Awards
 Ustar Wins Two GCD Design Awards
Time of issue : 2022-12-29 16:02:44
Ustar has recently won two awards - Gold Winner 2022, Smart Products 2022 - at the Contemporary Good Design Award (CGD).
See more information
Ustar has recently won two awards - Gold Winner 2022, Smart Products 2022 - at the Contemporary Good Design Award (CGD).
Ustar at MEDICA 2022
Ustar at MEDICA 2022
Time of issue : 2022-11-21 13:56:25
See more information
Medica 2022
Medica 2022
Time of issue : 2022-11-14 10:27:05
November 14-17 Dusseldorf, Germany, visit us at 3H92-2
See more information
November 14-17 Dusseldorf, Germany, visit us at 3H92-2

Contact us

Ustar Biotechnologies (Hangzhou) Ltd.  (Headquarters)
Add: 6/F, Building 2, 611 Dongguan Road, Binjiang District, Hangzhou, Zhejiang, P.R. China
Zip: 310053

Email: sales@bioustar.com    service@bioutsar.com
Tel: +86-571-88939358 (Sales) 
       +86-400-870-7025 (Service)

留言应用名称:
底部
描述:

Copyright Ustar Biotechnologies 2018. All rights reserved   浙ICP备20029265号  

Ustar